These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6775418)

  • 21. Factor VIII: C and factor VIII R: Ag in Argentine hemorrhagic fever.
    Molinas FC; Maiztegui JI
    Thromb Haemost; 1981 Aug; 46(2):525-7. PubMed ID: 6795740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative determination of blood factor VIII - like antigen (author's transl)].
    Blatný J; Procházka J; Bártová A; Fischerová E; Slepicka L; Skodová M
    Cas Lek Cesk; 1975 Apr; 114(17):526-8. PubMed ID: 1131845
    [No Abstract]   [Full Text] [Related]  

  • 23. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings: Inhibition of human platelet aggregation by the proteolytic effect of streptokinase (SK). Role of the factor VIII related antigen.
    Castillo R; Maragall S; Guisasola JA; Casals F; Ruiz C; Ordinas A
    Thromb Diath Haemorrh; 1975 Nov; 34(2):574. PubMed ID: 1198469
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparations.
    Toolis F; McKay G; Prowse CV
    Thromb Haemost; 1980 Feb; 43(1):25-7. PubMed ID: 6773169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Jun; 45(3):267-71. PubMed ID: 6792739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of virucidal heat treatment on proteins in human factor VIII concentrates.
    Thomas KB; McGrath KM; Taylor M; Young IF; Herrington RW; Schiff P
    Transfusion; 1988; 28(1):8-13. PubMed ID: 3124306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of thrombin on the clotting activity of factor VIII. A study with insolubilized thrombin.
    Vukovich T; Koller E; Doleschel W
    Thromb Haemost; 1978 Jun; 39(3):600-6. PubMed ID: 705688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enzyme immunoassay of factor VIII-related antigen (author's transl)].
    Okuda T; Masuyama H; Tanigawa T; Narihiro N; Fujimura Y; Takase T; Mikami S; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1980 Jul; 21(7):938-45. PubMed ID: 6775114
    [No Abstract]   [Full Text] [Related]  

  • 31. [Laser nephelometry of factor VIII - related antigen : for assay (author's transl)].
    Okuda T; Masuyama H; Matsuoka H; Tsukada S; Tanigawa T
    Rinsho Byori; 1981 Aug; 29(8):849-53. PubMed ID: 6796726
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetic analysis of bovine factor VIII in the hemophilic dog.
    Gentry PA; Kirby EP; Gentry RD
    Thromb Haemost; 1981 Aug; 46(2):485-8. PubMed ID: 6795739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automation of two-stage factor VIII assay.
    Stirling Y; Howarth DJ; Vickers M; North WR; Meade TW
    Thromb Haemost; 1978 Apr; 39(2):455-65. PubMed ID: 580993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardization of factor VIII: establishment and use of secondary standards.
    Panicucci F; Angeloni G; Arrighi S; Bucci E; DiMambro G; Lecchini L; Pitruzzello S; Positano M
    J Biol Stand; 1985 Apr; 13(2):115-21. PubMed ID: 3922990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of the quotient procoagulant f. VIII/antigenic f. VIII in disseminated intravascular coagulation (author's transl)].
    Aznar JA; Tascon A; Luño E; Rafecas J; Mayans J; Marty ML
    Sangre (Barc); 1977; 22(6):929-37. PubMed ID: 74859
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes of antigenecity of blood clotting factors during the process of blood coagulation (author's transl)].
    Fujimaki M; Iematsu S; Kato M; Kogiso H; Matsubara Y
    Rinsho Byori; 1978; 26(4):298-304. PubMed ID: 671776
    [No Abstract]   [Full Text] [Related]  

  • 37. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trial of an automatic apparatus for coagulation : Auto-Fi Dade (author's transl)].
    Conard J; Brunel R; Duvoisin G; Samama M
    Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):215-21. PubMed ID: 704338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of factor VIII--related antigen in cadaveric blood.
    Hargreaves LN; Todd AS
    Thromb Res; 1976 Sep; 9(3):301-5. PubMed ID: 982353
    [No Abstract]   [Full Text] [Related]  

  • 40. [Donor selection for the production of factor XIII preparations].
    Uteg KH; Tausendfreund K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.